Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2004;90:121-122; doi:10.1136/hrt.2003.019638
Copyright © 2004 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2004;90:121-122
© 2004 by BMJ Publishing Group & British Cardiac Society

EDITORIAL

Methotrexate eluting stents: to modify or cure?

A C Morton, J Gunn

Cardiovascular Research Group, University of Sheffield, Sheffield, UK

Correspondence to:
Correspondence to:
Dr Julian Gunn
Cardiovascular Research Group, Clinical Sciences Building, Northern General Hospital, Sheffield S5 7AU, UK; J.Gunn@Sheffield.ac.uk


Just as a single antibiotic cannot treat all infections, it may be that a variety of agents utilised in drug eluting stents will be necessary to treat restenosis

Keywords: methotrexate; restenosis; stents

Abbreviations: DES, drug eluting stents; PCI, percutaneous coronary intervention

The first 150 words of the full text of this article appear below.

With the introduction of drug eluting stents (DES) into routine percutaneous coronary intervention (PCI), many consider the battle against restenosis won. A more realistic viewpoint, perhaps, is that these are merely the early engagements in what will eventually turn out to be a longer war. The evidence base for sirolimus and paclitaxel eluting stents is impressive, with target vessel revascularisation < 5% at nine months in selected patients and lesions.12 One area of uncertainty is whether these two agents alone are sufficient to treat the wide variety of lesions found in day-to-day practice; just as a single antibiotic cannot treat all infections, it may be that a variety of agents will be necessary to treat restenosis. Another question is whether there will be room to further lower the restenosis rate (ideally to zero) in the "real world" where complex coronary artery lesions (long, diffuse, calcific, etc) are the norm rather . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Yang, W., Ge, J., Liu, H., Zhao, K., Liu, X., Qu, X., Li, W., Huang, Y., Sun, A., Zou, Y. (2006). Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model. Cardiovasc Res 72: 483-493 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.